FI
Fosun International Portfolio holdings
AUM
$360M
This Quarter Return
+12.61%
1 Year Return
+38.28%
3 Year Return
+3.77%
5 Year Return
+27.59%
10 Year Return
+94.55%
AUM
$1.57B
AUM Growth
+$1.57B
(-6%)
Cap. Flow
-$265M
Cap. Flow
% of AUM
-16.83%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
343
New
45
Increased
88
Reduced
68
Closed
37
Top Buys
| 1 |
BZUN
Baozun
BZUN
|
$20.3M |
| 2 |
MOMO
Hello Group
MOMO
|
$6.36M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.97M |
| 4 |
BBU
Brookfield Business Partners
BBU
|
$3.38M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.34M |
Top Sells
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
$94.3M |
| 2 |
Vipshop
VIPS
|
$53.6M |
| 3 |
DigitalBridge
DBRG
|
$37.5M |
| 4 |
Brookdale Senior Living
BKD
|
$33.9M |
| 5 |
Criteo
CRTO
|
$15.3M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
McDonald's
MCD
$226B
| $1.79M | 0.11% |
9,450
+4,900
| +108% | +$928K |
|
|
ATRS
102
DELISTED
Antares Pharma, Inc.
ATRS
| $1.77M | 0.11% |
591,708
+52,108
| +10% | +$156K |
|
103
Linde
LIN
$221B
| $1.75M | 0.11% |
10,168
+4,994
| +97% | +$860K |
|
104
Waste Management
WM
$90.4B
| $1.72M | 0.11% |
16,630
+1,030
| +7% | +$107K |
|
105
Chubb
CB
$111B
| $1.7M | 0.11% |
12,231
+1,250
| +11% | +$174K |
|
106
Colgate-Palmolive
CL
$67.7B
| $1.68M | 0.11% |
24,950
+19,150
| +330% | +$1.29M |
|
107
Nike
NKE
$110B
| $1.64M | 0.1% |
19,567
-1,760
| -8% | -$148K |
|
|
ADMS
108
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.61M | 0.1% |
223,959
+27,000
| +14% | +$194K |
|
|
NBRV
109
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $1.59M | 0.1% |
+666,589
| New | +$1.59M |
|
110
Acadia Pharmaceuticals
ACAD
$4.34B
| $1.57M | 0.1% |
59,000
-116,000
| -66% | -$3.09M |
|
111
American Express
AXP
$225B
| $1.57M | 0.1% |
14,355
+9,100
| +173% | +$993K |
|
112
Heron Therapeutics
HRTX
$204M
| $1.54M | 0.1% |
65,557
| – | – |
|
|
MRNS
113
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.54M | 0.1% |
390,860
-101,137
| -21% | -$398K |
|
114
Berkshire Hathaway Class A
BRK.A
$1.08T
| $1.51M | 0.1% |
5
-1
| -17% | -$301K |
|
115
Blackstone
BX
$131B
| $1.5M | 0.1% |
+43,250
| New | +$1.5M |
|
116
Eli Lilly
LLY
$661B
| $1.48M | 0.09% |
11,445
-3,215
| -22% | -$415K |
|
|
B
117
Barrick Mining Corporation
B
$46.3B
| $1.43M | 0.09% |
103,000
+63,000
| +158% | +$875K |
|
118
TSMC
TSM
$1.2T
| $1.42M | 0.09% |
35,120
-13,000
| -27% | -$525K |
|
119
Spyre Therapeutics
SYRE
$1.02B
| $1.4M | 0.09% |
176,148
+79,000
| +81% | +$628K |
|
120
VEON
VEON
$3.89B
| $1.38M | 0.09% |
660,608
| – | – |
|
|
VBIV
121
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $1.37M | 0.09% |
732,081
+87,000
| +13% | +$163K |
|
122
MacroGenics
MGNX
$121M
| $1.36M | 0.09% |
77,573
+11,111
| +17% | +$195K |
|
123
JPMorgan Chase
JPM
$824B
| $1.34M | 0.09% |
13,324
-11,686
| -47% | -$1.18M |
|
|
COWN
124
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.34M | 0.08% |
92,221
-429,940
| -82% | -$6.23M |
|
125
Travere Therapeutics
TVTX
$1.75B
| $1.31M | 0.08% |
56,837
| – | – |
|